There have been some important changes to the prescribing information for Eprex as a result of investigations into pure red cell aplasia (PRCA, erythroblastopenia) in patients treated with Eprex.
The subcutaneous route should not be used to administer Eprex to patients with chronic renal failure. Monitoring of reticulocyte count at regular intervals is recommended to detect possible occurrence of lack of efficacy. Recommended storage conditions (between 2°C and 8°C) should be adhered to at all times
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!